Abiopharma

🔍 Stuka Paul (Director)

Company: InspireMD, Inc. (NSPR)

Report Date: 2026-01-14

Detailed Transactions and Holdings:

• Acquired 132,076 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 523,704.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-14 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 444,195.00 | Footnotes: F2

Footnotes:

• F1: These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.
• F2: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
• REMARKS: Exhibit 24.1: Power of Attorney